OBJECTIVES: Hysterectomies are among one of the most common major surgical procedures performed in women. However, little is known regarding contemporary U.S. hysterectomy trends for women with benign disease with respect to both operative technique and perioperative complications. We sought to document these trends and to determine the association between these two factors with patient, surgeon, and hospital characteristics. MATERIALS AND METHODS: Hysterectomies performed for benign indications by generalist gynecologists from 2012-2014 were analyzed in the all-payer Maryland Health Services Cost Review Commission database. We included both open hysterectomies and those performed by minimally invasive surgery (MIS). Perioperative complications were defined using the Agency for Healthcare Research and Quality Patient Safety Indicators. Surgeon hysterectomy volume was analyzed by quartiles (0-5 ¼ very low, 6-10 ¼ low, 11-20 ¼ medium, and 21+ cases ¼ high volume). We utilized negative binomial regression and logistic regression to identify patient, surgeon, and hospital characteristics associated with MIS utilization and perioperative complications, respectively. RESULTS: A total of 5660 hospitalizations were identified during the study period. Most patients (61.5%) had an open hysterectomy; the remaining (38.6%) underwent a MIS procedure (25.1% robotic, 46.6% laparoscopic, and 28.3% vaginal 
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OBJECTIVES:
To describe the rationale, methods and 6 year experience with a real-world, single-surgeon voluntary registry for female pelvic reconstructive and incontinence procedures and the feasibility of capturing post-operative outcomes.
MATERIALS AND METHODS:
The primary goal of creating this registry was to establish the feasibility of a voluntary, surgeon-initiated prospective data capture to facilitate quality assessment for urogynecologic procedures. Secondary aims included identifying quality improvement opportunities based on the goal of 100% surgical case reporting. Data captured included baseline demographics, preoperative and postoperative symptoms using validated questionnaires (Pelvic Floor Distress Inventory [PFDI] and Pelvic Floor Impact Questionnaire [PFIQ] ) and physical examination findings (Pelvic Organ Prolapse Quantification [POP-Q]), surgical procedures and intra-and post-operative complications. The PRISM Registry sought to capture the surgical procedure and follow-up intervals according to the surgeon's standard practice without modification including 6 weeks and 6, 12, 24, and 36 months after surgery in a largely rural 150 mile radius catchment area. RESULTS: Between December 2010 and May 2016, surgical and clinical data for 843 individual cases from a single surgeon was captured within the PRISM Registry with IRB approval, comprising 100% surgical case capture. Cases included 113 hysterectomies, 1252 prolapse repairs (including 347 suspensions), 379 anti-incontinence procedures, 19 fistulas, 7 neo-vaginas, and 122 mesh excisions, totaling 2062 procedures on 652 unique patients. In some cases (n ¼ 444), patients were not asked to participate in long-term follow-up and thus were excluded from analysis (Figure 1) . The remaining 399 patients participated in post-operative visits with attendance of 95% at 6 weeks, 64% at 6 months, 51% at 12 months, 39% at 24 months, and 22% at 36 months. Of the patients who reported any positive prolapse or incontinence symptom on the PFDI, PFIQ, or POP-Q at 6 months (n ¼ 16), 68% returned for their 12 months surveillance visit (p ¼ 0.04). No clinical predictors for visit adherence were found at any other time point. Periodic internal auditing identified 6 transobturator sling erosions (7%) and in 2014 a different device and resident teaching methodology was selected with no subsequent sling erosions (n ¼ 42). CONCLUSION: The PRISM Registry captures urogynecologic procedures for the purposes of quality improvement. PRISM demonstrates that 100% case capture is feasible and fruitful for the highly motivated surgeon, although adequate long-term follow-up without structured patient incentives may be limited, outside a metropolitan area. Additional research is needed to better understand the role of surgical registries for quality improvement and to develop patientcentered strategies to increase long-term follow-up.
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